Graham Walmsley

Graham Walmsley

Director/Board Member at AKERO THERAPEUTICS, INC.

Net worth: 41 040 $ as of 2024-04-29

37 year
Health Technology
Finance
Consumer Services

Network origin in Graham Walmsley first degree

EntityEntity typeIndustry
University of California, Berkeley
408
College/University Other Consumer Services 408
Public Company Pharmaceuticals: Major 23
Stanford University School of Medicine
21
College/University Other Consumer Services 21
Public Company Pharmaceuticals: Major 20
11
Holding Company Investment Managers 11
Public Company Biotechnology 9
4
Subsidiary Investment Managers 4
3
Subsidiary Pharmaceuticals: Major 3
1
Subsidiary Miscellaneous Commercial Services 1
Public Company Biotechnology 1

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Graham Walmsley via their personal network

CompanySectorRelated peopleMain position
Stanford University College/University

Peter Kim

Steven J. Chu

Ramon Chavez Márquez

Joel Drescher

David Schaffer

Walter Greenleaf

Shuo Yang

Arsani William

Naseem Zojwalla

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Princeton University College/University

Andy Rappaport

Seth Harrison

Charles Wyman

William White

James Gillespie

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Graduate Degree

GILEAD SCIENCES, INC. Biotechnology

Andrew Cheng

Sandra Horning

Kitty Yale

Yuan Xu

Patrick Lamy

Chief Tech/Sci/R&D Officer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Peter Kim

David Schaffer

Vikram Bajaj

Yi Larson

Mindaugas Leika

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

Graduate Degree

Masters Business Admin

College/University

Jane Henderson

Jillian Manus

Carmine Stengone

Max Eisenberg

Aaron Royston

Undergraduate Degree

Director/Board Member

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Yale University College/University

Robert J. Adelman

David Myles

Judy Chou

Yuqi Wang

Doctorate Degree

Doctorate Degree

Doctorate Degree

Doctorate Degree

EXELIXIS, INC. Pharmaceuticals: Major

Francis McCormick

J. Garland

Tomas Jan Heyman

Rekha Hemrajani

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Biotechnology

Ian Clark

J. Garland

Sean Bohen

Sandra Horning

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Jack Nielsen

Jason Lettmann

Jaume Pons

Director/Board Member

Director/Board Member

Founder

University of Wisconsin College/University

Cynthia Butitta

Sean Bohen

Edward Zhong

Masters Business Admin

Undergraduate Degree

Doctorate Degree

Investment Managers

Seth Harrison

Timothy Rolph

Jonathan Young

Founder

Corporate Officer/Principal

Corporate Officer/Principal

Financial Conglomerates

Yuan Yuan

William White

Yi Larson

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of California San Diego College/University

Gorjan Hrustanovic

Amin Ronaghi

Patrick Lamy

Undergraduate Degree

Graduate Degree

Undergraduate Degree

The University of California, San Francisco College/University

Sean Bohen

Gorjan Hrustanovic

Peter Kushner

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

California Polytechnic State University (San Luis Obispo) College/University

John J. Schembri

J. Garland

Kristin Lanzi

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

MERCK & CO., INC. Pharmaceuticals: Major

Peter Kim

Mark Iwicki

Yuan Xu

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

TURG POIN Pharmaceuticals: Major

Robert J. Adelman

Yi Larson

Naseem Zojwalla

Director/Board Member

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Steven J. Chu

Ilan Gur

Vikram Bajaj

Director/Board Member

Founder

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Jaume Pons

Arindam Bose

Timothy Rolph

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Francis McCormick

Peter Kim

Steven J. Chu

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Robert J. Adelman

Aaron Royston

Jaume Pons

Founder

Private Equity Investor

Private Equity Investor

College/University

Ramon Chavez Márquez

William White

Edward Zhong

Corporate Officer/Principal

Graduate Degree

Undergraduate Degree

Stanford Graduate School of Business College/University

Roseanne Wincek

Arsani William

Caitlin Johnston

Masters Business Admin

Masters Business Admin

Director/Board Member

HARMONY BIOSCIENCES HOLDINGS, INC. Pharmaceuticals: Major

Jack Nielsen

Aaron Royston

Director/Board Member

Director/Board Member

Investment Managers

Jason Lettmann

Jaume Pons

Private Equity Investor

Consultant / Advisor

The Wharton School of the University of Pennsylvania College/University

Yi Larson

Christopher Fallone

Masters Business Admin

Graduate Degree

XILIO THERAPEUTICS, INC. Pharmaceuticals: Major

Tomas Jan Heyman

Yuan Xu

Director/Board Member

Director/Board Member

LEGEND BIOTECH CORPORATION Pharmaceuticals: Major

Tomas Jan Heyman

Yuan Xu

Director/Board Member

Chief Executive Officer

University of Pennsylvania College/University

Aaron Royston

Vikram Bajaj

Doctorate Degree

Graduate Degree

Investment Managers

Shuo Yang

Alex Teng

Private Equity Investor

Private Equity Investor

Financial Conglomerates

Jack Nielsen

Jennifer Lee

Corporate Officer/Principal

Private Equity Analyst

PANACOS PHARMACEUTICALS, INC. Biotechnology

Jack Nielsen

Jane Henderson

Director/Board Member

Director of Finance/CFO

PORTOLA PHARMACEUTICALS, INC. Pharmaceuticals: Major

J. Garland

John Moriarty

Chief Executive Officer

General Counsel

University of Iowa College/University

Jason Lettmann

Sandra Horning

Undergraduate Degree

Doctorate Degree

AMGEN INC. Pharmaceuticals: Major

J. Garland

John Moriarty

Sales & Marketing

Director/Board Member

INVIVYD, INC. Biotechnology

Jane Henderson

Tomas Jan Heyman

Director of Finance/CFO

Director/Board Member

Internet Retail

Sean Bohen

Judy Chou

Director/Board Member

Chief Executive Officer

Miscellaneous Commercial Services

Steffen Pietzke

Sasha Austin

Corporate Officer/Principal

Corporate Officer/Principal

APELLIS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Robert J. Adelman

Aaron Royston

Director/Board Member

Director/Board Member

GYROSCOPE THERAPEUTICS HOLDINGS PLC Biotechnology

Ian Clark

Sean Bohen

Director/Board Member

Director/Board Member

Dartmouth College College/University

Charles Wyman

Peter Kushner

Corporate Officer/Principal

Undergraduate Degree

Investment Managers

Daniel K. Nomura

Caitlin Johnston

Consultant / Advisor

Private Equity Investor

CITIGROUP INC. Major Banks

William White

Fred Lee

Corporate Officer/Principal

Private Equity Investor

Investment Managers

Kevin Bitterman

Max Eisenberg

Private Equity Investor

Compliance Officer

Miscellaneous Commercial Services

Roseanne Wincek

James Gillespie

Corporate Officer/Principal

Consultant / Advisor

Pharmaceuticals: Major

Kevin Bitterman

Mark Iwicki

Director/Board Member

Director/Board Member

KALA BIO, INC. Pharmaceuticals: Major

Kevin Bitterman

Mark Iwicki

Director/Board Member

Chief Executive Officer

Investment Managers

Arsani William

Edward Zhong

Analyst-Equity

Corporate Officer/Principal

Statistics

International

United States 47
Ireland 3
Denmark 2
United Kingdom 2

Sectoral

Health Technology 20
Consumer Services 15
Finance 13
Commercial Services 5
Retail Trade 2

Operational

Director/Board Member 372
Corporate Officer/Principal 197
Independent Dir/Board Member 98
Undergraduate Degree 92
Founder 76
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW